Meet the Boston Heart Leadership Team

The Boston Heart leadership team is made up of accomplished medical, scientific and business leaders. Their combined experience and expertise drive our company towards its mission—enabling everyone to improve health and prevent disease.


Scott Madel, President

Scott has consistently provided insightful and innovative leadership for organizational turn-around and profitable growth across healthcare. He has launched novel technologies throughout diverse markets and geographies, spanning multiple payer channels and within various product categories for start-ups, market-leaders, and multi-nationals. Bringing broad strategic awareness and real-world solutions-based experience in clinical diagnostics, Scott is passionate about improving the delivery of patient-centric solutions which enable practitioners to address cardiometabolic disease with advanced testing.


Ernst J. Schaefer, MD, Founder and Chief Medical Officer

Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of Coronary Heart Disease. He has made countless contributions to the National Cholesterol Education Program (NCEP) of the National Institutes of Health (NIH) and is a member of the National Lipid Association’s (NLA) Board of Directors.

Read More


Michael Dansinger, MD, Medical Director, Patient Wellness

Dr. Dansinger is a nationally recognized authority on dietary and lifestyle counseling for prevention and treatment of heart disease, type 2 diabetes, obesity, and related conditions. In 2011, he joined the Boston Heart team as the Medical Director of Patient Wellness. He led development of our personalized wellness solution to complement the unique diagnostic insights provided by our approach to cardiovascular disease characterization and management. He works directly with healthcare providers and their patients by providing training and expertise in Nutritional Planning and Lifestyle Coaching solutions specific to a patient’s personal cardiovascular risk.

Read More